NEW YORK, Aug. 10, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Immunomedics, Inc. (NASDAQ:IMMU), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Ralph Lauren Corporation (NYSE:RL), Alliant Energy Corporation (NYSE:LNT), TreeHouse Foods, Inc. (NYSE:THS), and Lincoln National Corporation (NYSE:LNC), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

IMMU DOWNLOAD: http://Fundamental-Markets.com/register/?so=IMMU VRTX DOWNLOAD: http://Fundamental-Markets.com/register/?so=VRTX RL DOWNLOAD: http://Fundamental-Markets.com/register/?so=RL LNT DOWNLOAD: http://Fundamental-Markets.com/register/?so=LNT THS DOWNLOAD: http://Fundamental-Markets.com/register/?so=THS LNC DOWNLOAD: http://Fundamental-Markets.com/register/?so=LNC

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Immunomedics, Inc. (NASDAQ:IMMU), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Ralph Lauren Corporation (NYSE:RL), Alliant Energy Corporation (NYSE:LNT), TreeHouse Foods, Inc. (NYSE:THS), and Lincoln National Corporation (NYSE:LNC) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 8th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

IMMUNOMEDICS, INC. (IMMU) REPORT OVERVIEW

Immunomedics' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Immunomedics reported revenue of $0.48MM vs $1.32MM (down 63.56%) and basic earnings per share -$0.21 vs -$0.55. For the twelve months ended June 30th, 2017 vs June 30th, 2016, Immunomedics reported revenue of $3.09MM vs $3.23MM (down 4.39%) and basic earnings per share -$1.47 vs -$0.62. Immunomedics is expected to report earnings on August 15th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.25. The estimated EPS forecast for the next fiscal year is -$0.98 and is expected to report on August 15th, 2018.

To read the full Immunomedics, Inc. (IMMU) report, download it here: http://Fundamental-Markets.com/register/?so=IMMU

-----------------------------------------

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) REPORT OVERVIEW

Vertex Pharmaceuticals' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Vertex Pharmaceuticals reported revenue of $752.16MM vs $544.14MM (up 38.23%) and basic earnings per share $0.82 vs $0.07 (up 1,071.43%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Vertex Pharmaceuticals reported revenue of $2,488.65MM vs $1,702.18MM (up 46.20%) and basic earnings per share $1.06 vs -$0.46. Vertex Pharmaceuticals is expected to report earnings on October 24th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.24. The estimated EPS forecast for the next fiscal year is $3.43 and is expected to report on January 30th, 2019.

To read the full Vertex Pharmaceuticals Incorporated (VRTX) report, download it here: http://Fundamental-Markets.com/register/?so=VRTX

-----------------------------------------

RALPH LAUREN CORPORATION (RL) REPORT OVERVIEW

Ralph Lauren's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Ralph Lauren reported revenue of $1,390.60MM vs $1,347.10MM (up 3.23%) and basic earnings per share $1.33 vs $0.73 (up 82.19%). For the twelve months ended March 31st, 2018 vs March 31st, 2017, Ralph Lauren reported revenue of $6,182.30MM vs $6,652.80MM (down 7.07%) and basic earnings per share $1.99 vs -$1.20. Ralph Lauren is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $1.99. The estimated EPS forecast for the next fiscal year is $7.15 and is expected to report on May 22nd, 2019.

To read the full Ralph Lauren Corporation (RL) report, download it here: http://Fundamental-Markets.com/register/?so=RL

-----------------------------------------

ALLIANT ENERGY CORPORATION (LNT) REPORT OVERVIEW

Alliant Energy's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Alliant Energy reported revenue of $816.10MM vs $765.30MM (up 6.64%) and basic earnings per share $0.43 vs $0.41 (up 4.88%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Alliant Energy reported revenue of $3,382.20MM vs $3,320.00MM (up 1.87%) and basic earnings per share $1.99 vs $1.64 (up 21.34%). Alliant Energy is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.75. The estimated EPS forecast for the next fiscal year is $2.25 and is expected to report on February 28th, 2019.

To read the full Alliant Energy Corporation (LNT) report, download it here: http://Fundamental-Markets.com/register/?so=LNT

-----------------------------------------

TREEHOUSE FOODS, INC. (THS) REPORT OVERVIEW

TreeHouse Foods' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, TreeHouse Foods reported revenue of $1,455.80MM vs $1,522.20MM (down 4.36%) and basic earnings per share -$0.36 vs -$0.60. For the twelve months ended December 31st, 2017 vs December 31st, 2016, TreeHouse Foods reported revenue of $6,307.10MM vs $6,175.10MM (up 2.14%) and basic earnings per share -$5.01 vs -$4.10. TreeHouse Foods is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.67. The estimated EPS forecast for the next fiscal year is $2.62 and is expected to report on February 21st, 2019.

To read the full TreeHouse Foods, Inc. (THS) report, download it here: http://Fundamental-Markets.com/register/?so=THS

-----------------------------------------

LINCOLN NATIONAL CORPORATION (LNC) REPORT OVERVIEW

Lincoln National's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Lincoln National reported revenue of $4,020.00MM vs $3,577.00MM (up 12.38%) and basic earnings per share $1.76 vs $1.84 (down 4.35%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Lincoln National reported revenue of $14,257.00MM vs $13,330.00MM (up 6.95%) and basic earnings per share $9.36 vs $5.09 (up 83.89%). Lincoln National is expected to report earnings on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $2.03. The estimated EPS forecast for the next fiscal year is $9.27 and is expected to report on January 30th, 2019.

To read the full Lincoln National Corporation (LNC) report, download it here: http://Fundamental-Markets.com/register/?so=LNC

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.